Syneron Medical Ltd. (NASDAQ:ELOS)
The Company designs, develops and markets innovative aesthetic medical products based on its ELOS, technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Great growth stock selling at a EV/Earnings ratio of just 11.
Recs
Hair-removal, pigment-lightening, leg vein and wrinkle-reduction, skin-tightening, skin-rejuvenation, reduction in appearence of cellulite: all magical words to an increasingly large population. Sure it is a crowded and competitive field, but their increased efforts in sales in the US and Canada, combined with 3 newly FDA-approved platforms: eLight, eLaser, and eMax, should bode well for them.
Recs
This is a no-brainer. ELOS has the most extensive laser product line in the industry and boasts the best margins in the industry. Look for this stock to jump right after their next earnings call.
Recs
Expect 3rd quarter positive e. surprise.
Analysts have lowered estimates, but company is maintaining previous guidance of higher 2nd half rev and net.
Recs
Great gross margin. Increasing sales. Middle East war is nearing end.
Recs
As the baby boomers age they will inevitably get fatter and uglier. Laser hair removal and aesthetic skin treatments will likely grow in popularity.
Recs
Picked by oceanbluela
Recs
I admit that I may have strayed across my competence line here. Fancy medical devices to pretty up the aging, aren't really within my comfort zone. However, looks incredibly undervalued. Balance sheet is fantastic, margins unbelievable and I do like the idea of this industry in an aging society. Trade publications indicate the products are superior, but I really can't say for sure.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 101 - 108 of 108 : « Previous 1 2 3 4 5 6